Sageworth Trust Company of South Dakota’s AstraZeneca AZN Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Buy	+2,405	New	+$452K	0.28%	41

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sageworth Trust Company of South Dakota's AZN Position: Q2 2026 in Review

Sageworth Trust Company of South Dakota opened a new position in AstraZeneca (AZN) in Q2 2026: 2,405 shares worth $456K. The stake represents 0.28% of the portfolio and ranks #41 among its holdings.

1,149 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Sageworth Trust Company of South Dakota held 2,405 shares of AstraZeneca worth $456K as of Q2 2026.
AstraZeneca was a new Sageworth Trust Company of South Dakota position in Q2 2026.
AstraZeneca made up 0.28% of Sageworth Trust Company of South Dakota's portfolio in Q2 2026, its #41 holding.
1,149 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q2 2026, filed 28 Jul 2026.